by Keenan Faulkner | Apr 27, 2012 | Discussion Paper, Perspectives
Introduction The gap between the growing demand for evidence to inform practice and our current state of knowledge calls for serious consideration about the best approach to developing a workforce capable of meeting those demands. As referenced in the discussion paper...
by Keenan Faulkner | Apr 20, 2012 | Discussion Paper, Perspectives
Introduction Over the past decade, the symbiotic relationship between the clinical trials enterprise (CTE) and the health care delivery system has been subject to increasing amounts of stress. During this period, the CTE has primarily focused on process improvement,...
by Denise Walker | Jan 27, 2012 | Commentary, Perspectives
In 1965, when Medicare was enacted, spending for prescription drugs was less than $4 billion—so low that no one thought to include a drug benefit as part of Medicare. By 2003, the cost and importance of drug therapy was so high that Medicare Part D was enacted. Drug...
